164 related articles for article (PubMed ID: 8235928)
21. Pharmacokinetic Data Are Predictive of
Connolly KL; Eakin AE; Gomez C; Osborn BL; Unemo M; Jerse AE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642924
[TBL] [Abstract][Full Text] [Related]
22. Grepafloxacin versus cefixime as single-dose therapy for uncomplicated gonorrhea in women.
Mroczkowski TF; Hook Iii EW; Jones RB; McCormack WM; Martin DH
Infect Dis Obstet Gynecol; 1997; 5(6):370-5. PubMed ID: 18476190
[TBL] [Abstract][Full Text] [Related]
23. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group.
Handsfield HH; Dalu ZA; Martin DH; Douglas JM; McCarty JM; Schlossberg D
Sex Transm Dis; 1994; 21(2):107-11. PubMed ID: 9071422
[TBL] [Abstract][Full Text] [Related]
24. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea.
Mogabgab WJ; Lutz FB
South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.
Judson FN; Ehret JM; Root CJ
Antimicrob Agents Chemother; 1983 Feb; 23(2):218-20. PubMed ID: 6301364
[TBL] [Abstract][Full Text] [Related]
26. Treatment of uncomplicated gonorrhea in women with single-dose cefonicid.
Handsfield HH; Murphy VL
Sex Transm Dis; 1985; 12(2):90-2. PubMed ID: 3923633
[TBL] [Abstract][Full Text] [Related]
27. Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations.
Forsyth S; Penney P; Rooney G
Int J STD AIDS; 2011 May; 22(5):296-7. PubMed ID: 21571983
[TBL] [Abstract][Full Text] [Related]
28. Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.
Handsfield HH; Murphy VL; Holmes KK
Antimicrob Agents Chemother; 1981 Dec; 20(6):839-40. PubMed ID: 6275788
[TBL] [Abstract][Full Text] [Related]
29. Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
de Koning GA; Tio D; van den Hoek JA; van Klingeren B
Br J Vener Dis; 1983 Apr; 59(2):100-2. PubMed ID: 6299449
[TBL] [Abstract][Full Text] [Related]
30. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
[TBL] [Abstract][Full Text] [Related]
32. Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation.
Taylor SN; Morris DH; Avery AK; Workowski KA; Batteiger BE; Tiffany CA; Perry CR; Raychaudhuri A; Scangarella-Oman NE; Hossain M; Dumont EF
Clin Infect Dis; 2018 Aug; 67(4):504-512. PubMed ID: 29617982
[TBL] [Abstract][Full Text] [Related]
33. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
34. Treatment of uncomplicated gonorrhea in men with single-dose moxalactam.
Handsfield HH
Sex Transm Dis; 1983; 10(4):191-4. PubMed ID: 6420908
[TBL] [Abstract][Full Text] [Related]
35. Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men.
Megran DW; Lefebvre K; Willetts V; Bowie WR
Antimicrob Agents Chemother; 1990 Feb; 34(2):355-7. PubMed ID: 2183719
[TBL] [Abstract][Full Text] [Related]
36. Treatment of uncomplicated gonorrhea with cefotaxime.
Handsfield HH; Holmes KK
Sex Transm Dis; 1981; 8(3):187-91. PubMed ID: 6270834
[TBL] [Abstract][Full Text] [Related]
37. Therapy of uncomplicated gonorrhea due to antibiotic-resistant Neisseria gonorrhoeae.
Kraus SJ; Reynolds GH; Rolfs RT
Sex Transm Dis; 1988; 15(4):234-43. PubMed ID: 3147528
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
[TBL] [Abstract][Full Text] [Related]
39. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
40. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
